Global Oligonucleotide Bioconjugation Service Market Research Report 2024

Publication ID:

PB511243239

Publication Date:

November 4, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Oligonucleotide bioconjugation service refers to the conjugation of oligonucleotides with other biomolecules such as peptides, antibodies, etc. This conjugation can be used in a variety of research and applications, including: drug delivery, vaccine development, and gene therapy.
The global Oligonucleotide Bioconjugation Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Oligonucleotide Bioconjugation Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oligonucleotide Bioconjugation Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Oligonucleotide Bioconjugation Service in Scientific Research is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Oligonucleotide Bioconjugation Service include WuXi TIDES, Bio-Synthesis Inc, Creative Biolabs, Creative Biogene (IntegrateRNA), CPC Scientific Inc., BOCSCI Inc., LifeTein, Ajinomoto, SBS Genetech, Medtide Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oligonucleotide Bioconjugation Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligonucleotide Bioconjugation Service.
The Oligonucleotide Bioconjugation Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oligonucleotide Bioconjugation Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oligonucleotide Bioconjugation Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
WuXi TIDES
Bio-Synthesis Inc
Creative Biolabs
Creative Biogene (IntegrateRNA)
CPC Scientific Inc.
BOCSCI Inc.
LifeTein
Ajinomoto
SBS Genetech
Medtide Inc.
Kaneka Corporation(Eurogentec)
Rockland
CellMosaic
Leinco
Lonza
ChemExpress
GTP Bioways
Biosynth
Segment by Type
Oligonucleotide-Peptide
Oligonucleotide-Antibody
Oligonucleotide-Lipid
Oligonucleotide-Toxin
Oligonucleotide-GalNAc
Other
Segment by Application
Scientific Research
Pharmaceuticals
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oligonucleotide Bioconjugation Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oligonucleotide Bioconjugation Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oligonucleotide-Peptide
1.2.3 Oligonucleotide-Antibody
1.2.4 Oligonucleotide-Lipid
1.2.5 Oligonucleotide-Toxin
1.2.6 Oligonucleotide-GalNAc
1.2.7 Other
1.3 Market by Application
1.3.1 Global Oligonucleotide Bioconjugation Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Scientific Research
1.3.3 Pharmaceuticals
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oligonucleotide Bioconjugation Service Market Perspective (2019-2030)
2.2 Global Oligonucleotide Bioconjugation Service Growth Trends by Region
2.2.1 Global Oligonucleotide Bioconjugation Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oligonucleotide Bioconjugation Service Historic Market Size by Region (2019-2024)
2.2.3 Oligonucleotide Bioconjugation Service Forecasted Market Size by Region (2025-2030)
2.3 Oligonucleotide Bioconjugation Service Market Dynamics
2.3.1 Oligonucleotide Bioconjugation Service Industry Trends
2.3.2 Oligonucleotide Bioconjugation Service Market Drivers
2.3.3 Oligonucleotide Bioconjugation Service Market Challenges
2.3.4 Oligonucleotide Bioconjugation Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oligonucleotide Bioconjugation Service Players by Revenue
3.1.1 Global Top Oligonucleotide Bioconjugation Service Players by Revenue (2019-2024)
3.1.2 Global Oligonucleotide Bioconjugation Service Revenue Market Share by Players (2019-2024)
3.2 Global Oligonucleotide Bioconjugation Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oligonucleotide Bioconjugation Service Revenue
3.4 Global Oligonucleotide Bioconjugation Service Market Concentration Ratio
3.4.1 Global Oligonucleotide Bioconjugation Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oligonucleotide Bioconjugation Service Revenue in 2023
3.5 Global Key Players of Oligonucleotide Bioconjugation Service Head office and Area Served
3.6 Global Key Players of Oligonucleotide Bioconjugation Service, Product and Application
3.7 Global Key Players of Oligonucleotide Bioconjugation Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oligonucleotide Bioconjugation Service Breakdown Data by Type
4.1 Global Oligonucleotide Bioconjugation Service Historic Market Size by Type (2019-2024)
4.2 Global Oligonucleotide Bioconjugation Service Forecasted Market Size by Type (2025-2030)
5 Oligonucleotide Bioconjugation Service Breakdown Data by Application
5.1 Global Oligonucleotide Bioconjugation Service Historic Market Size by Application (2019-2024)
5.2 Global Oligonucleotide Bioconjugation Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oligonucleotide Bioconjugation Service Market Size (2019-2030)
6.2 North America Oligonucleotide Bioconjugation Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Oligonucleotide Bioconjugation Service Market Size by Country (2019-2024)
6.4 North America Oligonucleotide Bioconjugation Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oligonucleotide Bioconjugation Service Market Size (2019-2030)
7.2 Europe Oligonucleotide Bioconjugation Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Oligonucleotide Bioconjugation Service Market Size by Country (2019-2024)
7.4 Europe Oligonucleotide Bioconjugation Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oligonucleotide Bioconjugation Service Market Size (2019-2030)
8.2 Asia-Pacific Oligonucleotide Bioconjugation Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Oligonucleotide Bioconjugation Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Oligonucleotide Bioconjugation Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oligonucleotide Bioconjugation Service Market Size (2019-2030)
9.2 Latin America Oligonucleotide Bioconjugation Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Oligonucleotide Bioconjugation Service Market Size by Country (2019-2024)
9.4 Latin America Oligonucleotide Bioconjugation Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oligonucleotide Bioconjugation Service Market Size (2019-2030)
10.2 Middle East & Africa Oligonucleotide Bioconjugation Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Oligonucleotide Bioconjugation Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Oligonucleotide Bioconjugation Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 WuXi TIDES
11.1.1 WuXi TIDES Company Details
11.1.2 WuXi TIDES Business Overview
11.1.3 WuXi TIDES Oligonucleotide Bioconjugation Service Introduction
11.1.4 WuXi TIDES Revenue in Oligonucleotide Bioconjugation Service Business (2019-2024)
11.1.5 WuXi TIDES Recent Development
11.2 Bio-Synthesis Inc
11.2.1 Bio-Synthesis Inc Company Details
11.2.2 Bio-Synthesis Inc Business Overview
11.2.3 Bio-Synthesis Inc Oligonucleotide Bioconjugation Service Introduction
11.2.4 Bio-Synthesis Inc Revenue in Oligonucleotide Bioconjugation Service Business (2019-2024)
11.2.5 Bio-Synthesis Inc Recent Development
11.3 Creative Biolabs
11.3.1 Creative Biolabs Company Details
11.3.2 Creative Biolabs Business Overview
11.3.3 Creative Biolabs Oligonucleotide Bioconjugation Service Introduction
11.3.4 Creative Biolabs Revenue in Oligonucleotide Bioconjugation Service Business (2019-2024)
11.3.5 Creative Biolabs Recent Development
11.4 Creative Biogene (IntegrateRNA)
11.4.1 Creative Biogene (IntegrateRNA) Company Details
11.4.2 Creative Biogene (IntegrateRNA) Business Overview
11.4.3 Creative Biogene (IntegrateRNA) Oligonucleotide Bioconjugation Service Introduction
11.4.4 Creative Biogene (IntegrateRNA) Revenue in Oligonucleotide Bioconjugation Service Business (2019-2024)
11.4.5 Creative Biogene (IntegrateRNA) Recent Development
11.5 CPC Scientific Inc.
11.5.1 CPC Scientific Inc. Company Details
11.5.2 CPC Scientific Inc. Business Overview
11.5.3 CPC Scientific Inc. Oligonucleotide Bioconjugation Service Introduction
11.5.4 CPC Scientific Inc. Revenue in Oligonucleotide Bioconjugation Service Business (2019-2024)
11.5.5 CPC Scientific Inc. Recent Development
11.6 BOCSCI Inc.
11.6.1 BOCSCI Inc. Company Details
11.6.2 BOCSCI Inc. Business Overview
11.6.3 BOCSCI Inc. Oligonucleotide Bioconjugation Service Introduction
11.6.4 BOCSCI Inc. Revenue in Oligonucleotide Bioconjugation Service Business (2019-2024)
11.6.5 BOCSCI Inc. Recent Development
11.7 LifeTein
11.7.1 LifeTein Company Details
11.7.2 LifeTein Business Overview
11.7.3 LifeTein Oligonucleotide Bioconjugation Service Introduction
11.7.4 LifeTein Revenue in Oligonucleotide Bioconjugation Service Business (2019-2024)
11.7.5 LifeTein Recent Development
11.8 Ajinomoto
11.8.1 Ajinomoto Company Details
11.8.2 Ajinomoto Business Overview
11.8.3 Ajinomoto Oligonucleotide Bioconjugation Service Introduction
11.8.4 Ajinomoto Revenue in Oligonucleotide Bioconjugation Service Business (2019-2024)
11.8.5 Ajinomoto Recent Development
11.9 SBS Genetech
11.9.1 SBS Genetech Company Details
11.9.2 SBS Genetech Business Overview
11.9.3 SBS Genetech Oligonucleotide Bioconjugation Service Introduction
11.9.4 SBS Genetech Revenue in Oligonucleotide Bioconjugation Service Business (2019-2024)
11.9.5 SBS Genetech Recent Development
11.10 Medtide Inc.
11.10.1 Medtide Inc. Company Details
11.10.2 Medtide Inc. Business Overview
11.10.3 Medtide Inc. Oligonucleotide Bioconjugation Service Introduction
11.10.4 Medtide Inc. Revenue in Oligonucleotide Bioconjugation Service Business (2019-2024)
11.10.5 Medtide Inc. Recent Development
11.11 Kaneka Corporation(Eurogentec)
11.11.1 Kaneka Corporation(Eurogentec) Company Details
11.11.2 Kaneka Corporation(Eurogentec) Business Overview
11.11.3 Kaneka Corporation(Eurogentec) Oligonucleotide Bioconjugation Service Introduction
11.11.4 Kaneka Corporation(Eurogentec) Revenue in Oligonucleotide Bioconjugation Service Business (2019-2024)
11.11.5 Kaneka Corporation(Eurogentec) Recent Development
11.12 Rockland
11.12.1 Rockland Company Details
11.12.2 Rockland Business Overview
11.12.3 Rockland Oligonucleotide Bioconjugation Service Introduction
11.12.4 Rockland Revenue in Oligonucleotide Bioconjugation Service Business (2019-2024)
11.12.5 Rockland Recent Development
11.13 CellMosaic
11.13.1 CellMosaic Company Details
11.13.2 CellMosaic Business Overview
11.13.3 CellMosaic Oligonucleotide Bioconjugation Service Introduction
11.13.4 CellMosaic Revenue in Oligonucleotide Bioconjugation Service Business (2019-2024)
11.13.5 CellMosaic Recent Development
11.14 Leinco
11.14.1 Leinco Company Details
11.14.2 Leinco Business Overview
11.14.3 Leinco Oligonucleotide Bioconjugation Service Introduction
11.14.4 Leinco Revenue in Oligonucleotide Bioconjugation Service Business (2019-2024)
11.14.5 Leinco Recent Development
11.15 Lonza
11.15.1 Lonza Company Details
11.15.2 Lonza Business Overview
11.15.3 Lonza Oligonucleotide Bioconjugation Service Introduction
11.15.4 Lonza Revenue in Oligonucleotide Bioconjugation Service Business (2019-2024)
11.15.5 Lonza Recent Development
11.16 ChemExpress
11.16.1 ChemExpress Company Details
11.16.2 ChemExpress Business Overview
11.16.3 ChemExpress Oligonucleotide Bioconjugation Service Introduction
11.16.4 ChemExpress Revenue in Oligonucleotide Bioconjugation Service Business (2019-2024)
11.16.5 ChemExpress Recent Development
11.17 GTP Bioways
11.17.1 GTP Bioways Company Details
11.17.2 GTP Bioways Business Overview
11.17.3 GTP Bioways Oligonucleotide Bioconjugation Service Introduction
11.17.4 GTP Bioways Revenue in Oligonucleotide Bioconjugation Service Business (2019-2024)
11.17.5 GTP Bioways Recent Development
11.18 Biosynth
11.18.1 Biosynth Company Details
11.18.2 Biosynth Business Overview
11.18.3 Biosynth Oligonucleotide Bioconjugation Service Introduction
11.18.4 Biosynth Revenue in Oligonucleotide Bioconjugation Service Business (2019-2024)
11.18.5 Biosynth Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

WuXi TIDES
Bio-Synthesis Inc
Creative Biolabs
Creative Biogene (IntegrateRNA)
CPC Scientific Inc.
BOCSCI Inc.
LifeTein
Ajinomoto
SBS Genetech
Medtide Inc.
Kaneka Corporation(Eurogentec)
Rockland
CellMosaic
Leinco
Lonza
ChemExpress
GTP Bioways
Biosynth

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂